DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Anastasilakis AD, Yavropoulou MP, Makras P.
Bisphosphonates or denosumab discontinuation and risk of fractures.
Maturitas 2017;
102: 75
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.